Compare ARK Genomic Revolution ETF (ARKG) vs Centene Corp (CNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Centene Corp — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while Centene Corp trades at $65.13 (market cap $32.05B). Which is the better fit depends on your goals.
| ARKG | CNC | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $68.72 |
52-Week Low | $24.02 | $26.17 |
Market Cap | — | $32.05B |
Enterprise Value | — | $21.10B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →
